Tate & Lyle announced that it is extending its partnership with APC Microbiome Ireland, a Science Foundation Ireland (SFI) Research Centre, through a new two-year research project to increase understanding of how dietary fibers can impact the functioning of the gut microbiome.  

Tate & Lyle welcomed the Ministry of Industry and Advanced Technology to its U.S. $2 million Customer Innovation and Collaboration Centre in Dubai, as part of an initiative to reduce sugar and calories in food and drink products in the UAE and the wider Middle East region.

Tate & Lyle PLC has announced that it has today completed the acquisition of Quantum Hi-Tech (Guangdong) Biological Co., Ltd (Quantum), a prebiotic dietary fiber business located in China.

Tate & Lyle is pleased to announce the opening of a new Customer Innovation and Collaboration Centre in Santiago, Chile.

Tate & Lyle PLC has announced it has acquired substantially all of the assets of Nutriati, an ingredient technology company developing and producing chickpea protein and flour. 

To accommodate the world’s collective sweet tooth and respond to the surge in demand for allulose, Tate & Lyle has expanded its production of its DOLCIA PRIMA syrup.

Tate & Lyle PLC, a global provider of food and beverage ingredients and solutions, is pleased to announce a new Equal Parental Leave Policy which will provide employees across the world with a minimum of 16 weeks full-paid parental leave covering birth, adoption, foster to adopt, and surrogacy.

Tate & Lyle has announced it has renewed its support of Enders-Salk Elementary School’s free breakfast program for the sixth year running.

Primient has entered the global food and industrial ingredients market with a portfolio of proven products and trusted application expertise across the food, beverage, paper, packaging, personal care, apparel, and animal nutrition industries.  

Tate & Lyle PLC has announced that it has signed an agreement to acquire Quantum Hi-Tech (Guangdong) Biological Co., Ltd, a prebiotic dietary fiber business in China, from ChemPartner Pharmatech Co., Ltd for a total consideration of US $237 million.